Skip to main content
Erschienen in: The journal of nutrition, health & aging 6/2018

30.04.2018 | Editorial

Nonpharmacological Treatment of Cognitive Impairment

verfasst von: John E. Morley, M. Berg-Weger, Janice Lundy

Erschienen in: The journal of nutrition, health & aging | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

Drugs available to treat dementia produce small improvements in cognition, but the clinical significance of these effects are questionable (1-3). In addition, they produce a variety of side effects including anorexia, weight loss, diarrhea, nausea, abdominal pain, dizziness, bradycardia, syncope and weakness. Thus, while dementia has traditionally been conceptualized from a medical model (4), it has become clear that dementia prognosis is strongly related to the environment and interpersonal relationships (5). Kitwood (5) identified 6 central needs for a person with dementia, viz., love, comfort, attachment, inclusion, occupation and identity. This has led to a variety of lifestyle and non-pharmacological interventions to manage cognitive impairment and behavioral and psychological symptoms of dementia (BPSD)(Table 1) (6).
Literatur
1.
Zurück zum Zitat Strohle A, Schmidt DK, Schultz F, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: A systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry 2015;23:1234–1249.CrossRefPubMed Strohle A, Schmidt DK, Schultz F, et al. Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: A systematic review and meta-analysis of effects on cognition in randomized controlled trials. Am J Geriatr Psychiatry 2015;23:1234–1249.CrossRefPubMed
2.
Zurück zum Zitat Muayqil T, Camicioli R. Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer’s disease and other dementias. Dement Geriatr Cogn Dis Extra 2012;2:546–572.CrossRefPubMedPubMedCentral Muayqil T, Camicioli R. Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer’s disease and other dementias. Dement Geriatr Cogn Dis Extra 2012;2:546–572.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379–397.CrossRefPubMed Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379–397.CrossRefPubMed
4.
Zurück zum Zitat Lyman KA. Bringing the social back in: A critique of the biomedicalization of dementia. Gerontologist 1989;29:597–605.CrossRefPubMed Lyman KA. Bringing the social back in: A critique of the biomedicalization of dementia. Gerontologist 1989;29:597–605.CrossRefPubMed
5.
Zurück zum Zitat Kitwood T. Toward a theory of dementia care: Ethics and interaction. J Clin Ethocs 1998;9:23–34. Kitwood T. Toward a theory of dementia care: Ethics and interaction. J Clin Ethocs 1998;9:23–34.
6.
Zurück zum Zitat Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharacological interventions to treat behavioural disturbances in older patients with dementia. The SENOR-OnTop series. BMJ Open 2017;7:e012759.CrossRefPubMedPubMedCentral Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharacological interventions to treat behavioural disturbances in older patients with dementia. The SENOR-OnTop series. BMJ Open 2017;7:e012759.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Panza GA, Taylor BA, MacDonald HV, et al. Can exercise improve cognitive symptoms of Alzheimer’s disease? J Am Geriatr Soc 2018;66:487–495.CrossRefPubMed Panza GA, Taylor BA, MacDonald HV, et al. Can exercise improve cognitive symptoms of Alzheimer’s disease? J Am Geriatr Soc 2018;66:487–495.CrossRefPubMed
8.
Zurück zum Zitat Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: Initial results from the Hellenic longitudinal investigation of ageing and diet. PLoS One. 2017;12(8):e0182048.CrossRefPubMedPubMedCentral Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: Initial results from the Hellenic longitudinal investigation of ageing and diet. PLoS One. 2017;12(8):e0182048.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Aridi YS, Walker JL, Wright ORL. The association between the Mediterranean dietary pattern and cognitive health: A systematic review. Nutrients 2017;9(7). Doi: 10.3390/nu9070674. Aridi YS, Walker JL, Wright ORL. The association between the Mediterranean dietary pattern and cognitive health: A systematic review. Nutrients 2017;9(7). Doi: 10.3390/nu9070674.
10.
Zurück zum Zitat Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: A systematic review and metaanalysis. J Alzheimers Dis 2014;39:271–282.PubMedPubMedCentralCrossRef Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: A systematic review and metaanalysis. J Alzheimers Dis 2014;39:271–282.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Farr SA, Price TO, Dominguez LJ, et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012;28;81–92.CrossRefPubMed Farr SA, Price TO, Dominguez LJ, et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012;28;81–92.CrossRefPubMed
12.
Zurück zum Zitat Farr SA, Niehoff ML, Ceddia MA, et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice. Physiol Behav 2016;165:328–338.CrossRefPubMed Farr SA, Niehoff ML, Ceddia MA, et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice. Physiol Behav 2016;165:328–338.CrossRefPubMed
13.
Zurück zum Zitat Dal-Pan A, Dudonne S, Bourassa P, et al. Cognitive-enhancing effects of a polyphenols-rich extract from fruits without changes in neuropathology in an animal model of Alzheimer’s disease. J Alzheimers Dis 2017;55:115–135.CrossRefPubMed Dal-Pan A, Dudonne S, Bourassa P, et al. Cognitive-enhancing effects of a polyphenols-rich extract from fruits without changes in neuropathology in an animal model of Alzheimer’s disease. J Alzheimers Dis 2017;55:115–135.CrossRefPubMed
14.
Zurück zum Zitat Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized trial. J Nutr Health Aging 2013;17:544–552.CrossRefPubMed Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized trial. J Nutr Health Aging 2013;17:544–552.CrossRefPubMed
15.
Zurück zum Zitat Abbatecola AM, Russo M, Barbieri M. Dietary patterns and cognition in older persons. Curr Opi Clin Nutr Metab Care 2018;21:10–13.CrossRef Abbatecola AM, Russo M, Barbieri M. Dietary patterns and cognition in older persons. Curr Opi Clin Nutr Metab Care 2018;21:10–13.CrossRef
16.
Zurück zum Zitat Morris MC, Tangney CC, Wang Y, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement 2015;11:1007–1014.CrossRefPubMedPubMedCentral Morris MC, Tangney CC, Wang Y, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement 2015;11:1007–1014.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Petursdottir AL, Farr SA, Morley JE, et al. Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 2008;63:1153–1160.CrossRefPubMed Petursdottir AL, Farr SA, Morley JE, et al. Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 2008;63:1153–1160.CrossRefPubMed
18.
Zurück zum Zitat Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care 2010;13:150–155.CrossRefPubMed Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care 2010;13:150–155.CrossRefPubMed
19.
Zurück zum Zitat Andrieu S, Guyonnet S, Coley N, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function I elderly adults with memory complaints (MAPT): A randomised, placebocontrolled trial. Lancet Neurol 2017;16:377–389.CrossRefPubMed Andrieu S, Guyonnet S, Coley N, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function I elderly adults with memory complaints (MAPT): A randomised, placebocontrolled trial. Lancet Neurol 2017;16:377–389.CrossRefPubMed
20.
Zurück zum Zitat Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, a vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomized controlled trial. Lancet 2015:385-:2255–2263.CrossRefPubMed Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, a vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomized controlled trial. Lancet 2015:385-:2255–2263.CrossRefPubMed
21.
Zurück zum Zitat Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 2017:177:51–58.CrossRefPubMedPubMedCentral Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 2017:177:51–58.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406–413.CrossRefPubMed Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406–413.CrossRefPubMed
23.
Zurück zum Zitat Woods B, O’Philbin L, Farrell EM, et al. Reminiscence therapy for dementia. Cochrane Database Syst Rev 2018 Mar 1;3:CD001120.PubMed Woods B, O’Philbin L, Farrell EM, et al. Reminiscence therapy for dementia. Cochrane Database Syst Rev 2018 Mar 1;3:CD001120.PubMed
24.
Zurück zum Zitat Coll-Planas L, Watchman K, Domenech S, et al. Developing evidence for football (soccer) reminiscence interventions within long-term care: A co-operative approach applied in Scotland and Spain. J Am Med Dir Assoc 2017;18:355–360.CrossRefPubMed Coll-Planas L, Watchman K, Domenech S, et al. Developing evidence for football (soccer) reminiscence interventions within long-term care: A co-operative approach applied in Scotland and Spain. J Am Med Dir Assoc 2017;18:355–360.CrossRefPubMed
25.
Zurück zum Zitat Wingbermuehle C, Bryer D, Berg-Weger, et al. Baseball reminiscence league: A model for supporting persons with dementia. J Am Med Dir Assoc 2014;15:85–9.CrossRefPubMed Wingbermuehle C, Bryer D, Berg-Weger, et al. Baseball reminiscence league: A model for supporting persons with dementia. J Am Med Dir Assoc 2014;15:85–9.CrossRefPubMed
26.
Zurück zum Zitat Spector A, Thorgrimsen L, Woods B, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J psychiatry 2003;183:248–254.CrossRefPubMed Spector A, Thorgrimsen L, Woods B, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J psychiatry 2003;183:248–254.CrossRefPubMed
27.
Zurück zum Zitat Kim K, Han JW, So Y, et al. Cognitive stimulation as a therapeutic modality for dementia: A meta-analysis. Psychiatry Investig 2017;14:626–639.CrossRefPubMedPubMedCentral Kim K, Han JW, So Y, et al. Cognitive stimulation as a therapeutic modality for dementia: A meta-analysis. Psychiatry Investig 2017;14:626–639.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Knapp M, Thorgrimsen L, Patel A, et al. Cognitive stimulation therapy for people with dementia: Cost-effectiveness analysis. Br J Psychiatry 2006;188:574–580.CrossRefPubMed Knapp M, Thorgrimsen L, Patel A, et al. Cognitive stimulation therapy for people with dementia: Cost-effectiveness analysis. Br J Psychiatry 2006;188:574–580.CrossRefPubMed
29.
Zurück zum Zitat Spector A, Gardner C, Orrell M. The impact of cognitive stimulation therapy groups on people with dementia: Views from participants, their carers and group facilitators. Aging Ment Health 2011;15:945–949.CrossRefPubMed Spector A, Gardner C, Orrell M. The impact of cognitive stimulation therapy groups on people with dementia: Views from participants, their carers and group facilitators. Aging Ment Health 2011;15:945–949.CrossRefPubMed
30.
Zurück zum Zitat Orrell M, Aguirre E, Spector A, et al. Maintenance cognitive stimulation therapy for dementia: Single-blind, multicenter, pragmatic randomized controlled trial. Br J Psychiatry 2014;204:454–461.CrossRefPubMed Orrell M, Aguirre E, Spector A, et al. Maintenance cognitive stimulation therapy for dementia: Single-blind, multicenter, pragmatic randomized controlled trial. Br J Psychiatry 2014;204:454–461.CrossRefPubMed
31.
Zurück zum Zitat Berg-Weger M, Tebb S, Henderson-Kalb J, et al. Cognitive stimulation therapy: A tool for your practice with persons with dementia? J Am Med Dir Assoc 2015;16:795–796.CrossRefPubMed Berg-Weger M, Tebb S, Henderson-Kalb J, et al. Cognitive stimulation therapy: A tool for your practice with persons with dementia? J Am Med Dir Assoc 2015;16:795–796.CrossRefPubMed
32.
Zurück zum Zitat Loraine J, Taylor S, McAllister M. Cognitive and physical stimulation therapy. J Am Med Dir Assoc 2014:15:140–141.CrossRefPubMed Loraine J, Taylor S, McAllister M. Cognitive and physical stimulation therapy. J Am Med Dir Assoc 2014:15:140–141.CrossRefPubMed
33.
Zurück zum Zitat Kawashima R, Hiller DL, Sereda SL, et al. SAIDO learning as a cognitive intervention for dementia care: A preliminary study. J Am Med Dir Assoc 2015;16:56–62.CrossRefPubMed Kawashima R, Hiller DL, Sereda SL, et al. SAIDO learning as a cognitive intervention for dementia care: A preliminary study. J Am Med Dir Assoc 2015;16:56–62.CrossRefPubMed
34.
Zurück zum Zitat Morley JE, Morris JC, Berg-Weger M, et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015;16:731–739.CrossRefPubMedPubMedCentral Morley JE, Morris JC, Berg-Weger M, et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015;16:731–739.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Morley JE, Cruz-Oliver DM. Cognitive stimulation therapy. J Am Med Dir Assoc 2014;15:689–691.CrossRefPubMed Morley JE, Cruz-Oliver DM. Cognitive stimulation therapy. J Am Med Dir Assoc 2014;15:689–691.CrossRefPubMed
36.
Zurück zum Zitat Volicer L. Toward better terminology of behavioral symptoms of dementia. J Am Med Dir Assoc 2012;13:3–4.CrossRefPubMed Volicer L. Toward better terminology of behavioral symptoms of dementia. J Am Med Dir Assoc 2012;13:3–4.CrossRefPubMed
37.
Zurück zum Zitat Tolson D, Rolland Y, Andrieu S, et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011;12:184–189.CrossRefPubMed Tolson D, Rolland Y, Andrieu S, et al. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc 2011;12:184–189.CrossRefPubMed
38.
Zurück zum Zitat Morley JE. New horizons in the management of Alzheimer’s disease. J Am Med Dir Assoc 2015;16:1–5.CrossRefPubMed Morley JE. New horizons in the management of Alzheimer’s disease. J Am Med Dir Assoc 2015;16:1–5.CrossRefPubMed
39.
Zurück zum Zitat Morley JE, Farr SA. Alzheimer mythology: A time to think out of the box. J Am Med Dir Assoc 2016;17:769–774.CrossRefPubMed Morley JE, Farr SA. Alzheimer mythology: A time to think out of the box. J Am Med Dir Assoc 2016;17:769–774.CrossRefPubMed
40.
Zurück zum Zitat Antczak J, Kowalska K, Klimkowicz-Mrowiec A, et al. Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: An open-label pilot study. Neuropsychiatr Dis Treat 2018;14:749–755.CrossRefPubMedPubMedCentral Antczak J, Kowalska K, Klimkowicz-Mrowiec A, et al. Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: An open-label pilot study. Neuropsychiatr Dis Treat 2018;14:749–755.CrossRefPubMedPubMedCentral
Metadaten
Titel
Nonpharmacological Treatment of Cognitive Impairment
verfasst von
John E. Morley
M. Berg-Weger
Janice Lundy
Publikationsdatum
30.04.2018
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 6/2018
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-018-1036-2

Weitere Artikel der Ausgabe 6/2018

The journal of nutrition, health & aging 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.